313 related articles for article (PubMed ID: 16338090)
1. Alteration of activator protein 1 DNA binding activity in gentamicin-induced hair cell degeneration.
Albinger-Hegyi A; Hegyi I; Nagy I; Bodmer M; Schmid S; Bodmer D
Neuroscience; 2006 Feb; 137(3):971-80. PubMed ID: 16338090
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
3. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
4. Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells.
Vasilevskaya IA; O'Dwyer PJ
Cancer Res; 1999 Aug; 59(16):3935-40. PubMed ID: 10463587
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
Krysan K; Lou MF
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
[TBL] [Abstract][Full Text] [Related]
7. Activation of transcription factor AP-1 and mitogen-activated protein kinases in aniline-induced splenic toxicity.
Khan MF; Kannan S; Wang J
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):86-93. PubMed ID: 16169568
[TBL] [Abstract][Full Text] [Related]
8. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids.
Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M
Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Cd-induced molecular events prior to cellular damage in primary rat hepatocytes in culture: activation of the stress activated signal protein JNK and transcription factor AP-1.
Hsiao CJ; Stapleton SR
J Biochem Mol Toxicol; 2004; 18(3):133-42. PubMed ID: 15252869
[TBL] [Abstract][Full Text] [Related]
10. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
[TBL] [Abstract][Full Text] [Related]
12. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
13. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway.
Nakamagoe M; Tabuchi K; Uemaetomari I; Nishimura B; Hara A
Hear Res; 2010 Mar; 261(1-2):67-74. PubMed ID: 20074632
[TBL] [Abstract][Full Text] [Related]
14. AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.
Grimm C; Wenzel A; Behrens A; Hafezi F; Wagner EF; Remé CE
Cell Death Differ; 2001 Aug; 8(8):859-67. PubMed ID: 11526439
[TBL] [Abstract][Full Text] [Related]
15. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.
Sundstedt A; Dohlsten M
J Immunol; 1998 Dec; 161(11):5930-6. PubMed ID: 9834073
[TBL] [Abstract][Full Text] [Related]
16. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
17. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation.
Wei X; Zhao L; Liu J; Dodel RC; Farlow MR; Du Y
Neuroscience; 2005; 131(2):513-21. PubMed ID: 15708492
[TBL] [Abstract][Full Text] [Related]
18. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
19. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase.
Liu D; Gao L; Roy SK; Cornish KG; Zucker IH
Circ Res; 2006 Oct; 99(9):1004-11. PubMed ID: 17008603
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
